How the alcohol lobby shapes health policy | Deadliest Drug Series
Len Lichtenfeld, a former deputy chief medical officer at the American Cancer Society (ACS), found himself grappling with a long-overdue apology in late 2024. His conscience was haunted by an exchange with a New York Times reporter almost a decade earlier, during which he defended the ACS’s controversial stance that consuming a drink or two a day was safe for cancer prevention.
Despite mounting evidence to the contrary, Lichtenfeld chose not to disclose crucial information he had received from the society’s epidemiologists. Moreover, a shocking revelation came to light – behind the scenes, the American Cancer Society was pocketing millions of dollars from the alcohol industry through an annual gala event held in New York City. This information, now disclosed for the first time, shed light on the conflicting interests at play within the organization.
Lichtenfeld confessed to feeling indirect pressure to keep these lucrative donors satisfied, a situation that he found morally conflicting. The repercussions of his actions came to a head in 2020 when he was laid off from ACS as part of budget cuts, coinciding with the society’s decision to change its official advice to recommend abstaining from alcohol for cancer prevention.
While ACS executives claimed that the shift in messaging was a result of routine updates to nutrition guidelines, they did acknowledge the persistent advocacy from staff epidemiologists for a stronger stance on alcohol consumption since the late 2010s. Chief Scientific Officer William Dahut affirmed that the revised advice in 2020 reflected the consensus of the entire committee, marking a necessary step forward in aligning with scientific evidence.
The episode with the reporter left a lasting impact on Lichtenfeld, highlighting the pervasive influence of special interests in shaping public health messaging. The United States’ complex relationship with alcohol, recognized as its deadliest drug after tobacco, underscores the urgent need for transparency and ethical decision-making in health advocacy.
A deeper investigation by STAT uncovered the alcohol industry’s adeptness at leveraging allies and financial resources to advance its agenda, reminiscent of tactics employed by the tobacco industry. By infiltrating health philanthropy, federal science, and political spheres, the alcohol trade has effectively stifled proposals that threaten its profitability, perpetuating a hidden addiction crisis.
The intertwined narratives of Len Lichtenfeld’s apology and the alcohol industry’s influence underscore the critical importance of independent and evidence-based public health advocacy. As we navigate the complexities of health messaging and policy-making, it is imperative to prioritize integrity, transparency, and the well-being of the public above all else.
